HuGE Literature Finder
Records
1
-
4
A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin. Journal of gastroenterology and hepatology 2016 Mar . Wei Lai, Zhang Mingxiang, Xu Min, Chuang Wan-Long, Lu Wei, Xie Wen, Jia Zhansheng, Gong Guozhong, Li Yueqi, Bae Si Hyun, Yang Yong-Feng, Xie Qing, Shumei Lin, Chen Xinyue, Niu Junqi, Jia Jidong, Garimella Tushar, Torbeyns Anne, McPhee Fiona, Treitel Michelle, Yin Philip D, Mo Li |
Significance of miRNA-122 in chronic hepatitis C patients with serotype 1 on interferon therapy. Hepatology research : the official journal of the Japan Society of Hepatology 2015 Jan 45 (1): 88-96. Kamo Yasuhiro, Ichikawa Tatsuki, Miyaaki Hisamitsu, Uchida Shinjirou, Yamaguchi Tohei, Shibata Hidetaka, Honda Takuya, Taura Naota, Isomoto Hajime, Takeshima Fuminao, Nakao Kazuhi |
Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2. Hepatology international 2014 Oct 8 (4): 550-9. Seki Nobuyoshi, Sugita Tomonori, Aida Yuta, Itagaki Munenori, Ishiguro Haruya, Sutoh Satoshi, Abe Hiroshi, Tsubota Akihito, Matsushima Masato, Aizawa Yosh |
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy. Liver international : official journal of the International Association for the Study of the Liver 2012 Jul 32 (6): 962-9. Huang Jee-Fu, Yu Ming-Lung, Huang Chung-Feng, Juo Suh-Hang Hank, Dai Chia-Yen, Hsieh Ming-Yen, Hou Nei-Jen, Yeh Ming-Lun, Hsieh Meng-Hsuan, Yang Jeng-Fu, Lin Zu-Yau, Chen Shinn-Chern, Shin Shyi-Jang, Chuang Wan-Lo |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: